A metastasis is a new tumor that forms when cancer cells break away from their original location and grow in a different part of the body. The most common sites where these secondary tumors develop are bone, liver, and lung. A metastasis keeps the identity of the original cancer: breast cancer that spreads to the liver, for example, is still breast cancer, not liver cancer. This distinction matters because treatment targets the cancer type, not the organ it landed in.
How Cancer Cells Spread
Metastasis isn’t a single event. It’s a chain of steps, each of which a cancer cell must survive to establish a new tumor somewhere else. First, cells break free from the original tumor and push into surrounding tissue. Then they enter a blood vessel or lymphatic channel, a process called intravasation. Once inside the circulatory system, they travel through the body, exit through the wall of a small vessel at a distant site, and begin growing into a new mass.
Most cancer cells that enter the bloodstream don’t survive the trip. Blood flow exerts physical force that can destroy them, and immune cells actively hunt them down. Some cancer cells recruit platelets to coat their surface like a shield, protecting them from both the shearing forces of blood flow and attack by immune cells. The cells that do survive and successfully lodge in a new organ still face the challenge of adapting to a completely different tissue environment. Only a small fraction manage to colonize and grow.
Cancer cells can move through tissue in different ways. Some travel in clusters, maintaining their connections to neighboring cells. Others detach individually and change shape to squeeze through tight spaces, almost like an amoeba. Interestingly, once these solo travelers reach a distant organ, they can reverse the process and reestablish cell-to-cell connections, which helps them form a solid new tumor.
Routes Cancer Uses to Travel
Cancer cells have two main highways out of a tumor: blood vessels and lymphatic channels. Blood vessels carry cells directly into the general circulation, where they can reach virtually any organ. Lymphatic channels, which are part of the immune system’s drainage network, carry cells to nearby lymph nodes first. But the two systems connect. Lymphatic fluid eventually drains into veins near the collarbone, so cancer cells that enter lymphatics can still end up in the bloodstream and travel to distant organs.
Which route a cancer takes first depends partly on the physical structure around the tumor. Lymphatic vessels have thinner walls than blood vessels, making them easier for cancer cells to enter. For tumors that can’t easily penetrate blood vessel walls, lymphatic channels act as a default pathway. This is why doctors often check nearby lymph nodes for cancer cells as an early indicator of spread.
Where Different Cancers Tend to Spread
Cancers don’t spread randomly. Each type has preferred destinations, likely driven by factors like blood flow patterns and the chemical environment of specific organs.
- Breast cancer most commonly spreads to bone, brain, liver, and lung.
- Lung cancer favors the adrenal glands, bone, brain, liver, and the opposite lung.
- Prostate cancer tends to reach the adrenal glands, bone, liver, and lung.
Bone is a particularly common destination across many cancer types. The rich blood supply of bone marrow and the growth factors it produces create a hospitable environment for circulating tumor cells.
Symptoms Depend on Location
The symptoms of metastatic cancer vary based on where the new tumors form, not where the cancer started. Bone metastases often cause deep, persistent pain and can weaken bones enough to cause fractures from minor stress. Liver metastases may cause abdominal swelling, nausea, or yellowing of the skin as liver function declines. Lung metastases can lead to shortness of breath, a persistent cough, or chest pain. Brain metastases frequently cause headaches, dizziness, vision changes, or seizures.
Some metastases produce no symptoms at all, especially when they’re small. These are sometimes discovered incidentally during imaging for another reason, or during routine follow-up scans after a cancer diagnosis.
How Metastasis Is Detected
Finding metastases typically involves imaging scans combined with biopsy when needed. CT scans and MRI are workhorses of cancer staging, revealing tumors in organs throughout the body. PET scans, which highlight areas of unusually high metabolic activity, are especially useful for spotting small metastases that might not yet be visible on a standard CT or MRI. Many cancer centers now use combined PET/CT or PET/MRI scans, which overlay metabolic and structural information in a single session to pinpoint the best location for biopsy.
A biopsy of a suspected metastasis confirms whether the cells match the original cancer. This step is important because a new tumor in the liver could be a primary liver cancer or a metastasis from somewhere else, and the treatment would be completely different.
What Stage IV Means
Doctors use the TNM system to classify cancer stage. The “M” in TNM stands for metastasis. M0 means no distant spread has been found. M1 means cancer has spread to distant parts of the body. Any cancer classified as M1 is considered Stage IV, regardless of the size of the original tumor or how many lymph nodes are involved.
Stage IV is the most advanced stage, but it’s not a single uniform situation. Some people have a single small metastasis in one organ, while others have widespread disease in multiple sites. Outcomes vary enormously depending on the cancer type, the number and location of metastases, and the treatments available.
Survival Rates Have Improved Significantly
A metastatic cancer diagnosis is serious, but survival statistics have shifted meaningfully over the past two decades. The overall five-year relative survival rate for distant-stage cancer reached 35% for people diagnosed between 2015 and 2021, up from 17% in the mid-1990s. That’s roughly double.
Some specific cancers have seen dramatic gains. Five-year survival for metastatic melanoma climbed from 16% to 35%, largely thanks to immunotherapy drugs that became available in the 2010s. Metastatic lung cancer survival rose from 2% to 10%, a fivefold increase that reflects both better targeted therapies and earlier detection. Myeloma survival nearly doubled, going from 32% to 62%. These numbers reflect real progress, though they also show that metastatic disease remains far more difficult to treat than cancer caught at an earlier stage.
How Metastatic Cancer Is Treated
Treatment for metastatic cancer is primarily systemic, meaning it works throughout the entire body rather than targeting one spot. This includes chemotherapy, immunotherapy, hormone therapy, and targeted drugs that block specific molecular pathways driving the cancer’s growth. The goal varies by situation. In some cases, treatment aims to shrink tumors and extend life by years. In others, the focus is on controlling symptoms and maintaining quality of life for as long as possible. A small but growing number of people with limited metastases, sometimes called oligometastatic disease, may be treated with the intent to eliminate all detectable cancer.
Systemic therapy can also be used before or after surgery or radiation when the risk of hidden spread is high. Tiny clusters of cancer cells too small to detect on scans, known as micrometastases, can be present even when imaging looks clear. Circulating tumor cells found in blood samples have emerged as a useful marker for this early, invisible spread in breast, prostate, lung, and colorectal cancers. Their presence helps doctors decide whether additional treatment after surgery is warranted.